(Q45921748)

English

Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information.

scientific article published in March 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

0 references

author name string

Linda Härmark

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

Eugène van Puijenbroek

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

Sabine Straus

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

Kees van Grootheest

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

34

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

221-231

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

The clinical picture of neuropathic pain.

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

EFNS guidelines on pharmacological treatment of neuropathic pain.

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Incidence rates and treatment of neuropathic pain conditions in the general population

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Detection, verification, and quantification of adverse drug reactions

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Pharmacovigilance: methods, recent developments and future perspectives

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Under-reporting of adverse drug reactions : a systematic review

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

A model for the future conduct of pharmacovigilance

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

The New Zealand Intensive Medicines Monitoring Programme.

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Long-term efficacy of pregabalin in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Adverse drug reaction reporting by patients in the Netherlands: three years of experience

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

1 reference

https://api.crossref.org/works/10.2165%2F11585030-000000000-00000

21 January 2018

Contribution of pharmacists to the reporting of adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21332246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11585030-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/21332246

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45921748&oldid=2207458654"